SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal DialysisIlias Bensouna, P Housset, Valérie Caudwell et al.|American Journal of Kidney Diseases|2021Cited by 136
Humoral response after a fourth “booster” dose of a Coronavirus disease 2019 vaccine following a 3-dose regimen of mRNA-based vaccination in dialysis patientsP Housset, Anne‐Laure Faucon, Latifa Hanafi et al.|Kidney International|2022Cited by 25
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patientsTimothée Bruel, Claire Delage, David Veyer et al.|Med|2023Cited by 16
Waning but persistent humoral response 6 months after the third dose of the mRNA BNT162b2 vaccine in hemodialysis and peritoneal dialysis patientsP Housset, Anne‐Laure Faucon, Latifa Hanafi et al.|Journal of Nephrology|2022Cited by 15